Be Familiar With the Latest Oral Multiple Sclerosis Meds

You'll hear about a flurry of new ORAL meds to treat multiple sclerosis (MS)...such as Mayzent, Vumerity, and Zeposia.

Expect patients with relapsing-remitting MS to usually start treatment right reduce flares and slow progression.

We're used to seeing the injectables (Avonex, Copaxone, etc) first-line. Or patients with more severe disease may jump right to a monoclonal antibody IV infusion (Lemtrada, Tysabri, etc).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote